Clinical Trial Update: 12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe [Phase 3]

View source ↗

Summary

An open-label Phase IIIb trial evaluating rosuvastatin (Crestor) in combination with ezetimibe for hypercholesterolemia and related cardiovascular disease; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease
• Hypercholesterolemia

Drugs mentioned

• CRESTOR (Rosuvastatin)
• Zetia (ezetimibe)

Snippet

Sponsor: AstraZeneca | Conditions: Hypercholesterolemia, Coronary Heart Disease | Phase 3 | Status: COMPLETED | Results posted: 2009-10-07